Eli Lilly (LLY) stock price, revenue, and financials

Eli Lilly market cap is $144.7 b, and annual revenue was $22.32 b in FY 2019

$144.7 B

LLY Mkt cap, 22-May-2020

$5.9 B

Eli Lilly Revenue Q1, 2020
Eli Lilly Gross profit (Q1, 2020)4.6 B
Eli Lilly Gross profit margin (Q1, 2020), %79.3%
Eli Lilly Net income (Q1, 2020)1.5 B

Eli Lilly Revenue

Eli Lilly revenue was $22.32 b in FY, 2019

Embed Graph

Eli Lilly Income Statement

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019

Revenue

23.1b19.6b20.0b21.2b22.9b24.6b22.3b

Revenue growth, %

(15%)2%6%

Cost of goods sold

4.9b4.9b5.0b5.7b6.1b6.4b4.7b

Gross profit

18.2b14.7b14.9b15.6b16.8b18.1b17.6b

Gross profit Margin, %

79%75%75%73%73%74%79%

R&D expense

5.3b5.3b

General and administrative expense

6.6b6.6b6.2b

Operating expense total

13.5b12.4b6.8b

Pre tax profit

5.9b3.0b2.8b3.4b2.2b3.8b5.3b

Income tax expense

1.2b609.8m381.6m636.4m2.4b563.7m565.6m

Net Income

4.7b2.4b2.4b2.7b(204.1m)3.2b8.3b

Quarterly

USDQ1, 2010Q2, 2010Q3, 2010Q4, 2010Q1, 2011Q2, 2011Q3, 2011Q4, 2011Q1, 2012Q2, 2012Q3, 2012Q4, 2012Q1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020

Revenue

5.5b5.7b5.7b23.1b5.8b6.3b6.1b24.3b5.6b5.6b5.4b22.6b5.6b5.9b5.8b4.7b4.9b4.9b4.6b5.0b5.0b4.9b5.4b5.2b5.2b5.8b5.7b5.7b6.4b6.1b5.1b5.6b5.5b5.9b

Cost of goods sold

1.1b1.0b987.6m4.4b1.2b1.2b1.3b5.1b1.2b1.1b1.2b4.8b1.2b1.2b1.2b1.2b1.2b1.3b1.2b1.2b1.2b1.3b1.5b1.4b1.3b1.6b1.6b1.6b1.7b1.6b1.1b1.1b1.2b

Gross profit

4.4b4.7b4.7b18.7b4.7b5.0b4.8b19.2b4.4b4.5b4.2b17.8b4.4b4.8b4.6b3.5b3.7b3.6b3.5b3.8b3.7b3.5b3.9b3.8b3.9b4.3b4.1b4.1b4.7b4.5b4.0b4.5b4.6b

Gross profit Margin, %

80%82%83%81%80%80%78%79%79%80%78%79%79%80%79%74%76%74%74%76%75%73%73%73%75%73%72%72%73%74%78%80%79%

R&D expense

1.0b1.2b1.2b4.9b1.1b1.3b1.3b5.0b1.2b1.3b1.3b5.3b1.3b1.3b1.4b1.1b1.2b1.2b1.0b1.2b1.1b1.2b1.3b1.2b1.2b1.3b1.3b1.2b1.3b1.3b1.2b1.4b1.4b1.4b

General and administrative expense

1.6b1.8b1.7b7.1b1.8b2.0b1.9b7.9b1.8b1.9b1.8b7.5b1.7b1.9b1.7b1.5b1.7b1.7b1.5b1.6b1.6b1.5b1.6b1.6b1.5b1.7b1.6b1.5b1.7b1.6b1.5b1.6b1.4b1.5b

Operating expense total

2.7b3.0b3.0b12.1b3.0b3.4b3.2b13.3b3.0b3.3b3.2b13.1b3.0b3.3b3.0b2.6b2.9b3.0b2.7b2.9b2.8b2.8b3.0b2.8b3.0b3.0b3.3b2.8b3.1b3.0b3.2b3.0b2.8b2.9b

Interest expense

47.5m47.2m185.5m45.8m45.1m45.0m186.0m45.3m43.0m47.0m177.8m40.3m40.3m39.8m37.8m35.5m38.1m40.9m36.8m39.3m43.4m43.2m47.2m46.6m53.6m61.9m61.2m63.3m69.4m86.5m110.9m107.4m92.5m

Interest income

11.0m16.3m51.9m15.5m17.8m22.2m79.9m26.1m27.2m25.7m105.0m23.6m29.7m32.2m34.4m33.6m28.8m21.4m20.6m21.2m24.2m23.5m29.1m32.6m36.9m45.1m45.5m41.2m32.1m30.6m19.4m17.3m14.3m

Pre tax profit

1.7b1.7b1.7b6.5b1.3b1.5b1.5b5.3b1.3b1.2b1.9b5.4b2.0b1.5b1.5b890.8m940.4m655.5m617.9m679.7m1.0b566.8m944.5m970.7m61.2m1.3b591.6m1.4b4.8m1.4b731.1m1.5b1.4b1.7b

Income tax expense

459.7m387.6m368.4m1.5b218.0m334.0m266.2m1.0b324.2m262.1m548.1m1.3b403.1m308.7m310.3m162.9m206.9m154.9m88.4m78.9m248.1m126.7m196.8m192.7m172.0m252.5m36.0m223.6m264.7m261.5m170.0m138.7m151.9m223.4m

Net Income

1.2b1.3b1.3b5.1b1.1b1.2b1.2b4.3b1.0b923.6m1.3b4.1b1.5b1.2b1.2b727.9m733.5m500.6m529.5m600.8m799.7m440.1m747.7m778.0m(110.8m)1.0b555.6m1.2b(259.9m)1.1b4.2b1.3b1.3b1.5b

Eli Lilly Balance Sheet

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019

Cash

3.8b3.9b3.7b4.6b6.5b8.0b2.3b

Accounts Receivable

588.4m566.7m558.6m736.9m4.5b5.2b4.5b

Prepaid Expenses

1.4b2.1b2.5b

Inventories

2.9b2.7b3.4b3.6b4.5b4.1b3.2b

Current Assets

13.1b12.2b12.6b15.1b19.2b20.5b13.7b

PP&E

8.0b8.0b8.1b8.3b8.8b8.9b7.9b

Goodwill

1.8b4.0b4.0b4.4b4.3b3.7b

Total Assets

35.2b37.2b35.6b38.8b45.0b43.9b39.3b

Accounts Payable

1.1b1.1b1.3b1.3b1.4b1.4b1.4b

Dividends Payable

523.5m530.3m539.0m548.1m590.6m650.8m671.5m

Short-term debt

3.7b1.1b1.5b

Current Liabilities

8.9b11.2b8.2b11.0b14.5b11.9b11.8b

Long-term debt

4.2b5.4b8.0b8.4b9.9b11.6b14.3b

Non-Current Liabilities

18.8b21.1b24.8b

Total Debt

4.2b5.4b8.0b8.4b13.6b12.8b15.8b

Common Stock

698.5m694.6m691.3m687.9m661.0m598.8m

Additional Paid-in Capital

5.1b5.3b5.6b5.6b5.8b6.6b6.7b

Retained Earnings

17.0b16.5b16.0b16.0b13.9b11.4b4.9b

Total Equity

17.6b15.4b14.6b14.1b11.7b10.9b2.7b

Debt to Equity Ratio

0.2 x0.3 x0.5 x0.6 x

Debt to Assets Ratio

0.1 x0.1 x0.2 x0.2 x

Financial Leverage

2 x2.4 x2.4 x2.8 x3.9 x4 x14.6 x

Quarterly

USDQ1, 2010Q2, 2010Q3, 2010Q4, 2010Q1, 2011Q2, 2011Q3, 2011Q4, 2011Q1, 2012Q2, 2012Q3, 2012Q4, 2012Q1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020

Cash

4.7b5.2b5.9b6.0b6.5b6.1b6.6b5.9b4.1b4.3b5.3b4.0b3.9b3.8b4.4b3.9b3.8b3.2b3.1b3.3b3.2b2.3b3.2b3.5b2.6b3.1b3.7b3.1b6.8b9.0b2.0b2.3b1.6b

Accounts Receivable

3.2b3.1b3.3b3.5b3.7b3.8b3.5b3.6b3.4b3.2b3.3b3.3b3.4b3.6b3.4b3.0b3.2b3.1b3.1b3.3b3.4b3.6b3.9b3.8b4.0b4.3b4.4b4.5b4.8b4.9b4.2b4.6b4.4b5.1b

Prepaid Expenses

1.0b1.1b1.2b608.9m1.1b867.3m799.1m654.9m998.5m953.3m790.1m822.3m987.9m988.9m853.4m1.1b1.1b821.5m797.0m730.1m762.4m792.0m789.5m756.5m821.6m1.0b1.1b1.6b1.7b1.9b2.2b2.3b2.4b2.8b

Inventories

2.5b2.2b2.7b2.5b2.8b2.9b2.5b2.3b2.4b2.3b2.6b2.6b2.6b2.7b3.0b3.0b3.2b2.8b3.0b3.3b3.4b3.7b3.8b3.9b4.0b4.3b4.4b4.6b4.2b4.1b3.1b3.2b3.1b3.1b

Current Assets

12.3b12.5b14.2b14.8b15.4b15.0b14.6b14.2b12.6b12.3b14.0b13.0b12.3b12.6b13.2b13.0b13.2b12.1b11.7b12.3b12.6b11.7b13.0b13.4b13.0b15.7b17.4b16.3b18.3b20.7b12.6b13.5b12.7b14.0b

PP&E

8.0b7.8b7.9b7.9b8.0b8.0b7.8b7.8b7.8b7.6b7.6b7.8b7.6b7.6b7.8b8.0b8.1b8.0b8.0b8.0b8.1b8.0b8.1b8.3b8.4b8.6b8.6b9.0b8.8b8.8b7.8b7.8b7.8b7.9b

Goodwill

1.4b1.4b1.5b3.9b4.0b4.1b4.0b4.0b4.0b4.2b4.3b4.4b4.4b4.3b4.4b3.9b3.8b3.8b3.8b

Total Assets

27.2b27.7b29.9b31.0b31.7b32.8b33.0b33.7b32.2b31.8b34.3b34.4b32.3b33.2b34.0b34.8b35.0b34.6b35.7b36.0b36.3b34.7b36.5b37.6b37.6b40.9b43.0b44.4b42.4b44.6b38.0b38.7b37.9b41.1b

Accounts Payable

964.0m950.3m1.0b1.1b1.2b1.2b1.2b1.1b1.2b1.2b1.3b1.2b974.4m1.1b1.2b1.1b1.1b1.0b1.2b1.2b1.2b1.2b1.2b1.2b1.2b1.3b1.2b1.3b1.3b1.3b1.2b1.2b1.1b1.2b

Dividends Payable

545.7m540.0m542.3m542.3m543.6m541.4m527.0m524.1m529.2m537.5m547.5m578.2m593.9m

Short-term debt

20.1m26.7m155.1m(18.2m)1.5b1.5b1.6b1.5b10.6m9.1m9.1m11.9m1.0b1.0b1.0b9.1m10.3m313.0m805.4m10.8m9.3m648.3m645.8m641.5m2.6b2.4b3.5b2.3b3.0b1.0b2.4b2.1b1.6b

Current Liabilities

5.7b6.3b6.1b7.1b7.7b8.6b8.2b8.9b6.6b6.6b7.0b8.4b7.6b8.4b8.1b6.6b7.4b7.6b8.3b8.2b8.3b7.3b8.4b8.3b10.4b11.3b12.7b11.5b13.1b10.8b11.2b11.9b10.8b12.6b

Long-term debt

6.7b6.9b7.0b6.8b5.1b5.2b5.5b5.5b5.4b5.5b5.5b5.5b4.4b4.3b4.3b5.3b5.3b5.3b7.4b8.0b8.1b7.5b8.7b8.7b7.6b9.9b9.9b9.4b9.2b11.7b13.6b13.7b13.7b14.0b

Non-Current Liabilities

11.1b11.2b11.4b11.5b10.1b9.9b9.8b11.2b10.9b10.9b11.3b11.2b9.8b9.6b9.0b9.8b9.6b9.4b12.4b13.1b12.8b12.3b13.4b13.7b13.1b15.5b15.4b18.2b17.7b19.6b24.2b24.0b23.6b25.3b

Total Debt

6.7b6.9b7.1b6.8b6.7b6.7b7.1b7.0b5.4b5.5b5.5b5.5b5.5b5.3b5.3b5.3b5.3b5.6b8.2b8.0b8.1b8.1b9.3b9.3b10.2b12.3b13.5b11.7b12.2b12.7b16.0b15.8b15.2b14.0b

Common Stock

721.3m721.3m721.3m721.3m724.1m724.1m724.1m724.1m725.8m725.8m725.8m716.6m704.5m704.7m704.7m700.1m699.0m696.6m694.1m693.3m693.0m690.3m690.3m690.4m690.0m688.5m688.5m680.8m673.5m667.1m607.1m603.7m600.4m598.1m

Additional Paid-in Capital

4.6b4.7b4.7b4.8b4.7b4.8b4.8b4.9b4.9b4.9b4.9b5.0b4.9b5.0b5.0b5.0b5.1b5.2b5.3b5.4b5.4b5.5b5.6b5.6b5.6b5.7b5.8b5.8b5.8b6.5b5.8b6.5b6.6b6.6b

Retained Earnings

11.1b11.3b12.6b12.7b13.8b13.9b15.1b14.9b15.9b15.7b17.1b16.1b16.5b16.6b17.8b17.7b17.2b17.4b16.7b16.1b16.9b16.2b15.8b16.6b15.9b15.6b16.1b16.6b14.2b14.4b4.9b4.3b5.0b5.9b

Total Equity

10.5b10.2b12.4b12.4b13.9b14.3b15.1b13.5b14.8b14.3b16.1b14.8b15.0b15.2b16.9b18.3b18.0b17.7b14.9b14.7b15.2b15.0b14.7b15.6b14.1b14.2b15.0b14.6b11.6b14.2b2.6b2.9b3.5b3.2b

Debt to Equity Ratio

0.6 x0.3 x

Debt to Assets Ratio

0.2 x0.2 x

Financial Leverage

2.6 x2.7 x2.4 x2.5 x2.3 x2.3 x2.2 x2.5 x2.2 x2.2 x2.1 x2.3 x2.2 x2.2 x2 x1.9 x1.9 x2 x2.4 x2.5 x2.4 x2.3 x2.5 x2.4 x2.7 x2.9 x2.9 x3 x3.6 x3.2 x14.8 x13.5 x10.9 x12.9 x

Eli Lilly Cash Flow

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019

Net Income

4.7b2.4b2.4b2.7b(204.1m)3.2b8.3b

Depreciation and Amortization

1.6b1.6b1.2b

Accounts Receivable

(357.0m)(996.7m)(127.2m)

Inventories

(253.9m)7.8m(258.7m)

Accounts Payable

916.3m(284.5m)(477.7m)

Cash From Operating Activities

5.7b4.4b2.8b4.9b5.6b5.5b4.8b

Purchases of PP&E

(1.0b)(1.2b)(1.1b)(1.0b)(882.1m)(6.9b)

Capital Expenditures

(1.1b)(1.2b)

Cash From Investing Activities

(2.1b)(3.9b)26.8m(3.1b)(3.8b)1.9b(8.1b)

Short-term Borrowings

2.7b(2.7b)1.3b

Long-term Borrowings

(10.5m)(1.0b)(2.0b)(200.0k)(630.6m)(1.0b)(2.9b)

Dividends Paid

(2.1b)(2.1b)(2.1b)(2.2b)(2.2b)(2.3b)(2.4b)

Cash From Financing Activities

(3.8b)(75.1m)(2.9b)(559.8m)142.6m(5.9b)(2.3b)

Net Change in Cash

2.0b1.5b(5.7b)

Free Cash Flow

4.5b4.3b

Quarterly

USDQ1, 2010Q2, 2010Q3, 2010Q4, 2010Q1, 2011Q2, 2011Q3, 2011Q4, 2011Q1, 2012Q2, 2012Q3, 2012Q4, 2012Q1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020

Net Income

1.2b1.3b1.3b5.1b1.1b1.2b1.2b4.3b1.0b1.9b3.3b4.1b1.5b2.8b4.0b727.9m1.5b2.0b529.5m1.1b1.9b440.1m1.2b2.0b(110.8m)897.2m1.5b1.2b957.5m2.1b4.2b5.6b6.8b1.5b

Depreciation and Amortization

(299.4m)1.3b340.9m1.4b385.9m747.9m1.1b1.5b381.5m745.4m1.1b348.8m697.2m1.0b357.5m726.0m1.1b385.5m759.2m1.2b386.9m782.5m1.2b422.8m848.0m1.3b356.5m603.9m891.9m273.6m

Accounts Receivable

319.1m(188.8m)361.8m

Inventories

(157.0m)203.1m(307.9m)

Accounts Payable

(363.9m)591.4m(336.1m)

Cash From Operating Activities

958.0m6.9b1.2b7.2b852.5m2.2b3.7b5.3b379.4m2.0b4.0b272.3m1.3b3.0b(84.8m)863.8m2.0b(326.9m)1.1b2.7b339.9m2.0b3.9b436.5m2.0b4.1b311.3m1.4b2.9b382.4m

Purchases of PP&E

(609.4m)(307.8m)(195.4m)(199.3m)(199.3m)(199.3m)(43.7m)(551.4m)(551.4m)(5.3b)(5.3b)(5.3b)(45.0m)(45.0m)(882.1m)(882.1m)(882.1m)(6.9b)(6.9b)(707.4m)(258.3m)

Capital Expenditures

(125.1m)(694.3m)(101.4m)(672.0m)(130.7m)(310.2m)(492.2m)(905.4m)(157.9m)(294.3m)(548.1m)(202.0m)(456.9m)(753.8m)(188.6m)(412.5m)(686.0m)(154.3m)(399.7m)(627.2m)(169.0m)(390.6m)(633.3m)(236.5m)(546.5m)(816.3m)(203.7m)

Cash From Investing Activities

(52.6m)(3.2b)(40.7m)(4.8b)(652.3m)(1.0b)(1.2b)(2.8b)1.4b103.4m(840.4m)388.4m(80.5m)(1.7b)160.8m343.2m(226.9m)(145.4m)(1.2b)(2.0b)(1.4b)(3.7b)(5.4b)(170.3m)3.0b2.6b(7.7b)(7.6b)(8.0b)(1.1b)

Short-term Borrowings

7.9m(123.9m)116.2m141.2m12.4m14.7m15.2m10.5m(2.3m)(304.9m)2.1b2.7b2.7b1.1m1.4m1.7m(497.5m)(125.7m)(1.2b)1.2b248.7m2.3b(1.9b)(1.6b)

Long-term Borrowings

(1.1m)(54.6m)(54.6m)(1.5b)(1.5b)(1.5b)(1.5b)(900.0k)(1.7m)(3.0m)(1.0b)(1.0b)(1.0b)(1.5m)(1.9b)(2.0b)(100.0k)(200.0k)(630.2m)(630.5m)(630.6m)(800.3m)(1.0b)(1.0b)(600.0m)(600.2m)(600.3m)(276.3m)

Dividends Paid

(539.2m)(2.2b)(543.2m)(2.2b)(544.6m)(1.1b)(1.6b)(2.2b)(531.1m)(1.1b)(1.6b)(524.1m)(1.1b)(1.6b)(527.9m)(1.1b)(1.6b)(538.3m)(1.1b)(1.6b)(547.4m)(1.1b)(1.6b)(587.3m)(1.2b)(1.7b)(637.2m)(1.2b)(1.8b)(671.3m)

Cash From Financing Activities

(547.0m)(2.0b)(713.8m)(2.4b)(2.1b)(2.6b)(3.2b)(4.4b)(1.7b)(2.3b)(2.8b)(595.1m)(1.3b)(1.7b)(701.2m)(1.6b)(2.2b)(816.4m)(237.0m)(834.6m)(875.7m)184.2m684.9m(3.9b)(4.7b)(4.3b)1.4b(1.2b)106.7m

Net Change in Cash

262.3m1.5b513.2m(70.7m)(1.8b)(1.6b)(603.3m)(1.9b)(82.2m)(232.3m)350.1m57.8m(64.5m)(664.4m)(806.8m)(556.1m)(632.8m)(1.4b)(428.4m)(177.4m)(2.0b)(1.5b)(857.8m)(3.5b)281.1m2.4b(6.0b)(6.4b)(638.5m)

Interest Paid

176.3m167.4m171.9m

Income Taxes Paid

861.0m140.0m120.0m943.0m992.0m130.0m150.0m150.0m

Free Cash Flow

832.9m6.2b1.1b6.6b721.8m1.8b3.2b4.4b221.5m1.7b3.5b70.3m869.3m2.3b(273.4m)451.3m1.3b(481.2m)675.2m2.1b170.9m1.6b3.2b200.0m1.4b3.3b107.6m

Eli Lilly Ratios

USDY, 2020

Financial Leverage

12.9 x

Eli Lilly Operating Metrics

FY, 2013FY, 2014FY, 2015FY, 2016

Phase III Trials Products

8 7 17 19

Projects in R&D Pipeline

57 57 65 66

Eli Lilly Employee Rating

3.62203 votes
Culture & Values
3.8
Work/Life Balance
3.9
Senior Management
3.3
Salary & Benefits
3.9
Career Opportunities
3.3
Source